Bouwinvest Real Estate Investors has invested $60m (€50m) in Blackstone’s US medical real estate investment trust BioMed Realty.

Bouwinvest, which invests internationally on behalf of Dutch pension fund BpfBouw, said it participated in Blackstone’s recapitalisation of BioMed Realty, a company which owns a US portfolio in core life science markets. 

Blackstone recently disclosed in its earnings statement that it had raised $7.5bn for its new life science office real estate perpetual vehicle.

Gijs Plantinga, Bouwinvest director North American Investments, said: “This exceptional investment opportunity meets our real value for life objectives by creating value in both financial and social terms.

“Our investment not only provides an attractive long-term return for Dutch pensioners but also helps facilitate important medical research.”

Bouwinvest, which has a target to grow its North American portfolio to $2bn by 2022, said the portfolio currently stands at $1.65bn.

“Bouwinvest sees additional long-term opportunities in affordable housing, single-family rentals and logistics in North America, as well as in alternative segments including life science office and data centres,” the Dutch investor said.

To read the digital edition of the latest IPE Real Assets magazine click here.